| # | Drug | Count |
|---|---|---|
| 0 | ECULIZUMAB | 9 |
| 1 | PREDNISONE | 9 |
| 2 | BELIMUMAB | 6 |
| 3 | FOLIC ACID | 6 |
| 4 | HYDROXYCHLOROQUINE | 6 |
| 5 | MYCOPHENOLATE MOFETIL | 6 |
| 6 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 6 |
| 7 | RAVULIZUMAB | 6 |
| 8 | METHOTREXATE SODIUM | 4 |
| 9 | PREDNISOLONE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BUPRENORPHINE AND NALOXONE | 1 | 0.0008 |
| 1 | PEGCETACOPLAN | 1 | 0.0005 |
| 2 | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | 1 | 0.0004 |
| 3 | PENICILLIN V POTASSIUM | 1 | 0.0004 |
| 4 | PYRIDOSTIGMINE BROMIDE ORAL | 1 | 0.0003 |
| 5 | HYDROXYZINE PAMOATE | 1 | 0.0003 |
| 6 | BELIMUMAB | 6 | 0.0002 |
| 7 | ECULIZUMAB | 9 | 0.0002 |
| 8 | METHYLPREDNISOLONE ACETATE | 1 | 0.0001 |
| 9 | VONOPRAZAN FUMARATE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Complement Inhibitor [EPC] | 15 |
| 1 | Corticosteroid [EPC] | 13 |
| 2 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 6 |
| 3 | Vitamin B12 [EPC] | 6 |
| 4 | Vitamin C [EPC] | 6 |
| 5 | Vitamin D [EPC] | 6 |
| 6 | Fluoroquinolone Antibacterial [EPC] | 3 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 3 |
| 8 | Expectorant [EPC] | 2 |
| 9 | Atypical Antipsychotic [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 1 | Complement Inhibitor [EPC] | 15 | 0.0003 |
| 2 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 6 | 0.0002 |
| 3 | Fluoroquinolone Antibacterial [EPC] | 3 | 0.0000 |
| 4 | Vitamin D [EPC] | 6 | 0.0000 |
| 5 | Vitamin B12 [EPC] | 6 | 0.0000 |
| 6 | Vitamin C [EPC] | 6 | 0.0000 |
| 7 | Tetracycline-class Drug [EPC] | 1 | 0.0000 |
| 8 | Central Nervous System Stimulant [EPC] | 1 | 0.0000 |
| 9 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 1 | 0.0000 |